Unadjusted | Age and sex adjusted | |||||
---|---|---|---|---|---|---|
OR | 95% CI | p | OR | 95% CI | p | |
Child characteristics | ||||||
Age, months | 0.97 | 0.93; 0.99 | 0.04 | 0.96 | 0.93; 0.99 | 0.04 |
Female sex, n (%) | 0.78 | 0.47; 1.29 | 0.33 | 0.76 | 0.45; 1.26 | 0.29 |
Severity of illness, VASb | 0.83 | 0.72; 0.94 | 0.01 | 0.83 | 0.73; 0.95 | 0.01 |
HIV status, n (%) | ||||||
Exposed | 0.74 | 0.37; 1.49 | 0.40 | 0.72 | 0.36; 1.47 | 0.37 |
Positive | 1.62 | 0.73; 3.56 | 0.23 | 1.68 | 0.75; 3.72 | 0.20 |
Weight-for-height z | 0.72 | 0.61; 0.86 | <0.001 | 0.75 | 0.62; 0.89 | 0.002 |
Height-for-age z | 0.95 | 0.80; 1.13 | 0.59 | 0.91 | 0.76; 1.09 | 0.33 |
MUAC, cm | 0.77 | 0.64; 0.91 | 0.003 | 0.79 | 0.66; 0.95 | 0.01 |
Symptoms on admission (%) | ||||||
Cough | 1.16 | 0.68; 1.97 | 0.58 | 1.14 | 0.67; 1.95 | 0.62 |
Diarrhea | 0.92 | 0.56; 1.51 | 0.73 | 0.87 | 0.53; 1.45 | 0.61 |
Fever | 0.94 | 0.57; 1.54 | 0.81 | 0.94 | 0.57; 1.55 | 0.81 |
Clinical signs on admission (%) | ||||||
Oedema | ||||||
Grade 1 | 1.12 | 0.42; 3.00 | 0.81 | 1.22 | 0.45; 3.28 | 0.69 |
Grade 2 | 0.80 | 0.40; 1.61 | 0.54 | 0.86 | 0.43; 1.75 | 0.68 |
Grade 3 | 0.55 | 0.31; 0.99 | 0.05 | 0.63 | 0.34; 1.15 | 0.13 |
Flaky paint dermatosis | 0.91 | 0.32; 2.54 | 0.855 | 0.94 | 0.33; 2.66 | 0.91 |
Laboratory data on admission | ||||||
C-reactive protein, mg/l | ||||||
> 10 | 0.87 | 0.51; 1.47 | 0.61 | 0.88 | 0.52; 1.49 | 0.64 |
Hemoglobin, g/dl | 1.12 | 0.98; 1.29 | 0.09 | 1.13 | 0.99; 1.29 | 0.06 |
Clinical data at transition | ||||||
Edema at time of transition | ||||||
Grade 1 | 0.53 | 0.24; 1.12 | 0.10 | 0.53 | 0.23; 1.16 | 0.11 |
Grade 2 | 1.91 | 0.31; 11.6 | 0.48 | 3.28 | 0.47; 22.45 | 0.23 |
Weight at transition, kg | 0.72 | 0.58; 0.87 | 0.001 | 0.64 | 0.48; 0.84 | 0.001 |
Diarrhoea during stabilization | 1.02 | 0.96; 1.09 | 0.39 | 1.02 | 0.96; 1.08 | 0.54 |
Duration of stabilization phase | 0.97 | 0.92; 1.02 | 0.27 | 0.96 | 0.92; 1..02 | 0.24 |